Supported By: An independent educational grant from United Therapeutics, a public benefit company
OMNI Hotel, Momentum EFG

Program Description

Come join Drs. Jean Elwing, Steven Nathan, and Ioana Preston at this exciting live symposium on Monday, October 7, 2024 at 6:00am! While gaining knowledge on the latest treatments in PH-ILD, enjoy a healthy start to your morning with breakfast and a smoothie. Pulmonary hypertension among patients with interstitial lung diseases (PH-ILD) is currently under-recognized and is associated with increased morbidity, mortality, and healthcare burden. Individualized treatment approaches need to be incorporated in the continuum of care to improve early detection, accurate diagnosis, and improved patient outcomes. In this live symposium, expert faculty will inform and guide on recent insights to screen for, detect, and accurately diagnose PH-ILD. The presentation will use didactic, case-based, and conversational formats to provide practical guidance and increase familiarity with the latest best-practice approaches for treatment and management of PH-ILD, to ultimately improve the quality of life of patients.

These symposia are not supported, endorsed, or accredited by the American College of Chest Physicians, unless otherwise noted.

Speakers

Moderator: Steven Nathan, MD
Inova Fairfax Hospital
Medical Director, Advanced Lung Disease and Transplant Program
Falls Church, VA

Presenter: Jean Elwing, MD
University of Cincinnati
Professor of Medicine; Director, Pulmonary Hypertension Program
Cincinnati, OH

Presenter: Ioana Preston, MD
Tufts University School of Medicine; Tufts Medical Center
Associate Professor of Medicine; Director, Pulmonary Hypertension Center
Boston, MA